Phase 4
N=300
Nutrition, Physical Performance & Fitness in Indian School Children
Physical Fitness · Nutritional Status
Bottom Line
View on ClinicalTrials.gov: NCT00876018 ↗Enrolled (actual)
300
Serious AEs
0.0%
Results posted
Aug 2017
Primary outcome: Primary: Change From Baseline in Maximal Aerobic Capacity (VO2max)- 12 Inch Step Test After 4 Months — 36.8; 37.9; 37.0; 38.9 mL/kg/min. — p=0.004
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Nutritional supplement (Other); Placebo (Other)
- Age
- Pediatric · 7+ yrs
- Sex
- All
- Sponsor
- GlaxoSmithKline
- Primary completion
- Dec 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Maximal Aerobic Capacity (VO2max)- 12 Inch Step Test After 4 Months |
36.8; 37.9; 37.0; 38.9; 37.6; 37.8 | 0.004 sig |
| PRIMARY Change From Baseline in Aerobic Capacity-shuttle Test (VO2peak) After 4 Months |
31.6; 32.8; 32.4; 39.1; 38.6; 38.2 | 0.002 sig |
| PRIMARY Change From Baseline in Time Taken for 40 Meter (m) Sprint After 4 Months |
9.0; 8.9; 8.9; 8.6; 8.9; 8.639 | 0.153 |
| PRIMARY Change From Baseline in Visual Reaction Time After 4 Months |
958; 932; 939; 863; 884; 864 | 0.143 |
| SECONDARY Change From Baseline in Maximal Handgrip Strength for Dominant and Non-dominant Hand After 4 Months |
9.7; 9.4; 9.8; 11.1; 10.6; 10.9 | — |
| SECONDARY Change From Baseline in Time to Fatigue After 4 Months |
12.31; 12.36; 11.13; 14.71; 14.62; 14.03 | — |
| SECONDARY Change From Baseline in Rate of Decline of Muscle Strength After 4 Months |
0.38; 0.38; 0.42; 0.36; 0.33; 0.35 | — |
| SECONDARY Change From Baseline in Hemoglobin Level After 4 Months |
12.9; 12.94; 12.88; 12.7; 12.60; 12.60 | — |
| SECONDARY Change From Baseline in Ferritin Level After 4 Months |
27.59; 20.17; 24.48; 38.78; 23.89; 25.79 | — |
| SECONDARY Change From Baseline in Soluble Transferring Receptors (sTr) After 4 Months |
5.91; 6.20; 5.98; 5.75; 5.99; 6.01 | — |
| SECONDARY Change From Baseline in C-reactive Protein Level After 4 Months |
0.20; 0.30; 0.40; 0.40; 0.20; 0.40 | — |
| SECONDARY Change From Baseline in Vitamin B2 Level After 4 Months |
1.56; 1.52; 1.57; 1.22; 1.47; 1.56 | — |
| SECONDARY Change From Baseline in Vitamin B6 Level After 4 Months |
33.77; 34.28; 39.27; 59.66; 37.79; 39.77 | — |
| SECONDARY Change From Baseline in Vitamin B12 Level After 4 Months |
210.03; 213.02; 224.02; 427.82; 218.30; 220.44 | — |
| SECONDARY Change From Baseline in Folate Level After 4 Months |
583.68; 585.29; 592.82; 1013.40; 592.41; 592.93 | — |
| SECONDARY Change From Baseline in Vitamin C Level After 4 Months |
0.69; 0.61; 0.72; 1.49; 0.77; 0.76 | — |
Summary
The purpose of this study is to evaluate the effect of nutritional supplement on physical performance measures of apparently healthy school going children in India.
Eligibility Criteria
Inclusion Criteria
- Boys and girls between ages 7-10.5 years
- Z score of height for age and weight for age of 0 to < -3
- Good general health at screening
- Understands and is willing, able and likely to comply with all study procedures and restrictions
- Written informed consent from the parents/ guardians and writtent assent by the study participant
Exclusion Criteria
- Severe anemia (Hb<8 g% )
- Cardiovascular disease on clinical examination or history
- Any underlying respiratory disease with impairment of lung function
- Physical disability Children consuming nutritional supplements (tonics, syrups, tablets or chews) and/ or health food drinks on a regular basis
- Recent history [3mo] of serious infections, injuries and/ or surgeries
- Participation in any nutritional study in the last 1 year
- Indication that they are likely to move within the period of study intervention
- Any known food allergies like peanut allergy, gluten allergy
- Family members of an employee of the Sponsor or the study site.
Data sourced from ClinicalTrials.gov (NCT00876018). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.